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RAM function is dependent on Kapβ2-mediated nuclear entry
Thomas GONATOPOULOS-POURNATZIS*1 and Victoria H. COWLING*2
*MRC Protein Phosphorylation Unit, College of Life Sciences, University of Dundee, Dow Street, Dundee DD1 5EH, U.K.
Eukaryotic gene expression is dependent on the modification of
the first transcribed nucleotide of pre-mRNA by the addition
of the 7-methylguanosine cap. The cap protects transcripts from
exonucleases and recruits complexes which mediate transcription
elongation, processing and translation initiation. The cap is
synthesized by a series of reactions which link 7-methylguanosine
to the first transcribed nucleotide via a 5′ to 5′ triphosphate bridge.
In mammals, cap synthesis is catalysed by the sequential action
of RNGTT (RNA guanylyltransferase and 5′-phosphatase) and
RNMT (RNA guanine-7 methyltransferase), enzymes recruited
to RNA pol II (polymerase II) during the early stages of
transcription. We recently discovered that the mammalian cap
methyltransferase is a heterodimer consisting of RNMT and the
RNMT-activating subunit RAM (RNMT-activating mini-protein).
RAM activates and stabilizes RNMT and thus is critical for
cellular cap methylation and cell viability. In the present study
we report that RNMT interacts with the N-terminal 45 amino
acids of RAM, a domain necessary and sufficient for maximal
RNMT activation. In contrast, smaller components of this RAM
domain are sufficient to stabilize RNMT. RAM functions in the
nucleus and we report that nuclear import of RAM is dependent
on PY nuclear localization signals and Kapβ2 (karyopherin β2)
nuclear transport protein.
Key words: capping, karyopherin β2 (Kapβ2), 7-methyl-
guanosine, mRNA cap methylation, RNA guanine-7 methyltrans-
ferase (RNMT), RNMT-activating mini-protein (RAM).
INTRODUCTION
In eukaryotes, RNA pol II (polymerase II) transcripts are
synthesized as precursors which undergo a complex series of
processing events prior to translation. The first processing event
is the addition of the cap, an inverted 7-methylguanosine group
joined to the first transcribed nucleotide via a 5′ to 5′ triphosphate
bridge [1–4]. In higher eukaryotes the first transcribed nucleotides
are also methylated in a variety of species-specific configurations.
The cap is uniquely found on RNA pol II transcripts and
is critical for transcript expression. The cap structure protects
transcripts from exonucleases and recruits complexes, including
CBC (cap-binding complex) and eIF4F (eukaryotic initiation
factor 4F) complex, which mediate transcription elongation,
splicing, nuclear export and translation initiation [1]. The cap
is present on the transcript throughout its lifetime and the process
of decapping initiates RNA degradation [5].
Nascent transcripts are synthesized with a 5′ triphosphate
on the first transcribed nucleotide to which 7-methylguanosine
is added by three enzymic activities [1–4]. A triphosphatase
removes the terminal phosphate and a guanylyltransferase adds
guanosine monophosphate to create the structure G(5′)ppp(5′)X
(X is the first transcribed nucleotide). Subsequently, an RNA
cap methyltransferase methylates the guanosine cap on the N-
7 position to create the basic cap structure, m7G(5′)ppp(5′)X. The
capping enzymes are recruited to the phosphorylated RNA pol
II C-terminal domain at the initial stages of transcription, which
places them in the proximity of the emergent nascent transcript
[6,7]. In mammals, the guanylyltransferase and triphosphatase are
contained on a single peptide, RNGTT (RNA guanylytransferase
and 5′-phosphatase), and the cap methyltransferase is a distinct
protein, RNMT (RNA guanine-7 methyltransferase). RNGTT
and RNMT are recruited to elongating RNA pol II [8,9],
and are rate-limiting for gene expression and cell proliferation
[8,10,11].
RNMT activity and expression were found to be dependent
on a previously uncharacterized nuclear protein called RAM
(RNMT-activating mini-protein) [12]. RAM increases RNMT
cap methyltransferase activity 5-fold in vitro and in cells RAM
is required for transcript cap methylation. RAM also protects
the RNMT protein from degradation, although the mechanism
involved is not known [12]. Since RNMT expression and
function is dependent on RAM, it is perhaps unsurprising that
RAM was found to be critical for gene expression and cell
proliferation.
RAM is a 118-amino-acid protein in humans and is conserved
in vertebrate species. The amino acid sequence of RAM bears
little homology to other human proteins (Figure 1A) [12]. Several
functional domains have been characterized (summarized in
Figure 1A). The N-terminal 55 amino acids of RAM contain the
RAD (RNMT-activation domain), which interacts with RNMT
and stimulates cap methyltransferase activity. Amino acids 56–
90 form the NR domain, which has an enrichment of arginine
and asparagine residues and binds to RNA. The NR domain is
not required to increase cap methyltransferase activity in vitro;
however, it may increase the recruitment of transcripts to RNMT
in cells. Amino acids 91–118 form the QYP domain which has an
enrichment of tyrosine, glutamine and proline residues, although
its function is unknown.
In the present study we determine that all three domains of
RAM are critical for RAM function and characterize the QYP
domain as a mediator of nuclear import.
Abbreviations used: HA, haemagglutinin; HEK, human embryonic kidney; IF, immunofluorescence; Kapβ2, karyopherin β2; NLS, nuclear localization
signal; pol II, polymerase II; RAD, RNMT-activation domain; RAM, RNMT-activating mini-protein; RNGTT, RNA guanylyltransferase and 5′-phosphatase;
RNMT, RNA guanine-7 methyltransferase; WT, wild-type.
1 Present address: Banting and Best Department of Medical Research and Donnelly Centre, University of Toronto, 160 College Street, Toronto, Ontario,
Canada, M5S 3E1
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Figure 1 The RAM RAD, NR and QYP domains are required for RAM function
(A) Depiction of human RAM domains investigated in this study. RAD, amino acids 1–55, interacts with RNMT and stimulates its activity. NR domain, amino acids 56–90, is an RNA-binding domain.
QYP domain, amino acids 91–118, is uncharacterized. Two PY NLSs at amino acids 98 and 114 are indicated. (B) HeLa cells were transfected with pcDNA5 RAM-GFP, RAM-GFP mutants or GFP
alone. At 3 days following transfection, Western blots were performed to detect the antigens indicated in cell extracts. Molecular masses are indicated in kDa. (C) HeLa cells were co-transfected
with RAM or control siRNA (c), and pcDNA5 RAM-GFP, RAM-GFP mutants or GFP alone. At 3 days after transfection the number of cells relative to siRNA control/pcDNA5 GFP transfection were
calculated. The histogram depicts the average for three independent experiments and the error bars indicate +− S.D. ***P < 0.001 using Student’s t test in comparison with RAM siRNA/pcDNA5 GFP
transfection.
MATERIALS AND METHODS
Cell culture and transfections
HeLa and HEK (human embryonic kidney)-293 cells were
cultured in DMEM (Dulbecco’s modified Eagle’s medium)/10%
FBS, in 5%CO2 at 37 ◦C. HeLa cells were transiently transfected
with pcDNA5- or pcDNA4-based constructs in 6-well dishes
using LipofectamineTM 2000 (Invitrogen). HEK-293 cells were
transiently transfected with pcDNA4-based constructs using
calcium phosphate. siRNA was purchased from the Dharmacon
siGENOME collection [RAM, D-021286-01; RNMT, D-019525-
01; Kapβ2-1 (karyopherin β2-1), D-011308-01; Kapβ2-2, D-
011308-02], and transfected using LipofectamineTM RNAiMAX
(Invitrogen). Non-targeting siRNA (D-001210-02) was used as a
negative control. Cells were lysed 48 h post-transfection.
Cell proliferation
HeLa cells (105) were transfected with 50 μM siRNA and 0.5 μg
of pcDNA5 HA-RNMT and 0.5 μg of pcDNA5 Fg-RAM or
RAM-GFP expression constructs, using LipofectamineTM 2000
(Invitrogen). The cDNAs utilized were resistant to siRNA via si-
lent mutation of wobble codons. Two days following transfection,
cells were counted using a Countess cell counter (Invitrogen).
Cloning
Constructs were created using standard cloning procedures.
Constructs were made resistant to siRNA by site-directed
mutagenesis of the siRNA-binding site using the QuikChange®
Site-Directed Mutagenesis kit (Stratagene). RAM siRNA 1-
resistant cDNA was made using the oligonucleotide 5′-GTT-
TGAAGAGATGTTTGCGTCGCGCTTTACGGAGAATGACA-
AGGAGTATCAGGAATACCTGAAACG-3′. RNMT siRNA
1-resistant cDNA was made using the oligonucleotide, 5′-AGCC-
ATATCCTGCAAATGAGTCCAGCAAGTTAGTCAGCGAGA-
AGGTGGATGACTATGAACATGCAGC-3′.All constructs were
sequence verified. Primers are available on request.
Cell extract preparation and immunoprecipitation
Cell extracts were lysed in Triton lysis buffer (10 mM Tris/HCl,
pH 7.5, 50 mM NaCl, 50 mM NaF, 30 mM Na4P2O7, 10%
glycerol, 0.5% Triton X-100 and protease inhibitors) and debris
was removed by centrifugation at 15000 g for 15 min at 4 ◦C.
c© The Authors Journal compilation c© 2014 Biochemical Society
RAM functional domains 475
Protein concentration was determined using the Bradford reagent
and diluted to 1 mg/ml. For immunoprecipitations, 0.5 mg of
cellular proteins were incubated with 1 μg of polyclonal RNMT
antibodies or isotype control plus 25 μl of Protein A/G–Sepharose
(Santa Cruz Biotechnology), 10 μl of anti-HA (haemagglutinin)
agarose (Sigma) or 10 μl of GFP-Trap (ChromoTek) for 4 h
at 4 ◦C. Resins were washed in Triton lysis buffer (10 mM
Tris/HCl, pH 7.5, 50 mM NaCl, 50 mM NaF, 30 mM Na4P2O7,
10% glycerol and 0.5% Triton X-100) and resuspended in 50 μl
of Laemmli buffer. A total of 20% of the immunoprecipitate and
10 μg of input were resolved by SDS/PAGE.
Western blotting
Proteins resolved by SDS/PAGE were transferred on to a
PVDF membrane (Millipore). Membranes were incubated with
polyclonal anti-RNMT antibodies (Cowling laboratory), poly-
clonal anti-RAM antibodies (Cowling laboratory), monoclonal
anti-HA antibodies (Sigma), monoclonal anti-GFP antibodies
(Roche) and polyclonal anti-β-tubulin antibodies (Santa Cruz
Biotechnology) for 1 h at room temperature (18–22 ◦C).
Secondary anti-sheep, anti-mouse and anti-rabbit antibodies, and
Pico chemiluminescence reagents (Thermo Scientific) were used
according to the manufacturer’s instructions.
Recombinant protein production
pGEX-6P-1-based vectors were transduced into BL21(DE3)
Escherichia coli cells and grown in LB broth. At a density of
D600 = 0.6, 1 litre cultures were induced with 0.5 mM IPTG for
16 h at 4 ◦C. Cells were resuspended in 15 ml of lysis buffer
(50 mM Tris/HCl, pH 7.5, 150 mM NaCl, 1% Triton X-100,
1 mM EDTA, 1 mM EGTA, 0.1% 2-mercaptoethanol, 0.2 mM
PMSF and 1 mM benzamidine) and sonicated 8 times on ice for
15 s. Insoluble material was removed by centrifugation for 30 min
at 60000 g. Glutathione–Sepharose (1 ml, GE Healthcare) was
incubated with the soluble material for 1 h, washed in lysis buffer
and protein was eluted in 5 ml of elution buffer (50 mM Tris/HCl,
pH 7.5, 150 mM NaCl, 1 mM EGTA, 0.07% 2-mercaptoethanol,
1 mM benzamidine, 0.03%Brij-35 and 50 mM glutathione). The
presence of RAM in the samples was verified by MS.
In vitro GST-fusion purification
Recombinant GST–RAM proteins (0.5 nmol) and 0.1 nmol
of recombinant RNMT in 500 μl of Triton lysis buffer were
incubated with 15 μl of glutathione–Sepharose at 4 ◦C for 3 h.
Glutathione–Sepharose was washed in Triton lysis buffer and
resuspended in 50 μl of Laemmli buffer. Purified proteins and
inputs were resolved by SDS/PAGE followed by Coomassie Blue
staining or Western blotting. The binding assays of RAM and
Kapβ2 were performed as described previously [12a]. Briefly,
0.5 nmol of GST–RAM were incubated with 0.2 nmol of
Kapβ2 in TB buffer (20 mM Hepes, pH 7.3, 10 mM potassium
acetate, 2 mM magnesium acetate, 2 mM EGTA, 2 mM DTT and
20% glycerol). The complexes were purified with glutathione–
Sepharose, extensively washed in TB buffer and visualized by
Western blotting.
Cap methylation activity assay
The cap methylation activity assay was performed according to
[11]. A guanosine-capped unmethylated substrate 32P-labelled
on the α-phosphate (Gp*ppG-RNA) was produced as follows.
A total of 200 ng of a 55-base strand of in vitro transcribed
RNA was incubated in a 10 μl reaction at 37 ◦C for 30 min
with 100 ng of recombinant human RNGTT, 2 μl (10 μCi) of
[α-32P]GTP and 1 μl of RNAsin (Promega) in reaction buffer
(0.05 M Tris/HCl, pH 8.0, 6 mM KCl and 1.25 mM MgCl2).
RNA was purified by ammonium acetate precipitation. In the
cap methyltransferase assay, 15 nM GST–RAM or mutants were
pre-incubated with 15 nM RNMT at 4 ◦C for 15 min. A total
of 2 ng of capped RNA was incubated with the proteins and
100 nM S-adenosylmethionine at 37 ◦C for 10 min in reaction
buffer. Following the reaction, RNA was purified, precipitated
and resuspended in 4 μl of 50 mM sodium acetate and 0.25 unit
of P1 nuclease for 30 min at 37 ◦C. Cap (Gp*ppG) and methyl-
cap (m7Gp*ppG) were resolved in 0.4 M ammonium sulphate
TLC using polyethyleneimine–cellulose plates. Standards were
visualized by UV light to establish correct migration. Labelled
spots were visualized and quantified by autoradiography, and
percentage conversion of GpppG into m7GppG was calculated.
RNA extraction and real-time qPCR
RNA was extracted using GeneJET RNA purification kit (Thermo
Scientific). PCR was performed using Quanta Biosciences SYBR
Green FastMix for iQ. RNA (500 ng) was converted into cDNA
using Quanta qScript cDNA Synthesis kit. cDNA (0.2 μl) was
used in real-time PCR reactions. The primers used are available
on request. PCR products were sequence verified.
Fluorescence microscopy
HeLa cells expressing RAM–GFP were fixed with 4%
paraformaldehyde in PBS for 10 min, washed in TBST (TBS
plus 0.1% Triton X-100) for 5 min and permeabilized with 1%
Nonidet P40 in TBST. Cells were washed for 10 min in TBST and
counterstained with 1 μg/ml DAPI in TBST. Cells were mounted
in 2.5% DABCO (1,4-diazadicyclo[2.2.2]octane) and visualized
by fluorescence microscopy (Zeiss LSM 700). Endogenous RAM
and RNMT IF (immunofluorescence) analysis was performed
as described previously [12]. The nuclear to cytoplasmic ratio
of GFP-tagged RAM mutants was calculated using the Volocity
software (PerkinElmer). Briefly, DAPI staining was used to define
the nuclei and phalloidin and tubulin staining was used to define
the whole cell. The cytoplasm was defined by subtracting the
nuclei from the whole cell. The average nuclear and cytoplasmic
intensity of GFP–RAM mutants from multiple cells in a single im-
age was calculated. The nuclear to cytoplasmic ratio was estimated
and the average +− S.D. from 12 independent images is presented.
RESULTS
The RAD, NR and QYP domains of RAM are required for cell
proliferation
In order to characterize and explore the relationship between the
different RAM functions, a series of mutants were constructed.
Full-length human RAM is 118 amino acids. The truncation
mutants created were the RAD, amino acids 1–55; the NR domain
(RNA-binding), amino acids 56–90; and the uncharacterized
QYP domain, amino acids 91–118 (Figure 1A). Previously
RAM had been demonstrated to be rate-limiting for mammalian
cell proliferation; however, the critical domains had not been
defined [12]. Therefore HeLa cells were depleted for endogenous
RAM using RAM siRNA and transfected with pcDNA5-based
constructs which express RAM–GFP or GFP alone (Figure 1B).
The RAM–GFP constructs used throughout the present study
have silent mutations which generate transcripts resistant to RAM
siRNA. Two days following transfection, cells were counted and
expressed as values relative to cells transfected with control
siRNA and GFP alone (Figure 1C). As observed previously,
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Figure 2 RAM 1–45 activates RNMT
(A) Recombinant GST–RAM WT, truncation mutants or GST alone were incubated with recombinant RNMT. GST–RAM complexes were purified on glutathione–Sepharose, resolved by SDS/PAGE
and co-purified RNMT was visualised by Coomassie Blue staining and Western blotting (WB). Molecular masses are indicated in kDa. (B) HeLa cells were transfected with pcDNA5 HA-RNMT or
pcDNA5 (c), and pcDNA4 RAM-GFP (RAM WT), RAM-GFP mutants or GFP. Immunoprecipitations (IP) were performed with anti-HA and anti-GFP antibodies. Western blots were performed to detect
GFP, RAM, HA and RNMT in inputs and immunoprecipitates. (* indicates cross-reacting antibody heavy or light chain). (C) Cap methyltransferase assay was performed using 15 nM RNMT plus
15 nM GST–RAM, truncation mutants or GST control. Protein complexes were incubated with [32P]GpppG transcript and S-adenosylmethionine for 10 mins. Following the reaction, transcripts were
digested and GpppG and m7GpppG were resolved by TLC and visualized by phosphoimaging. A representative image is shown. The average fold change in cap methyltransferase activity compared
with that generated by RNMT alone for six independent experiments is depicted. Error bars indicate +− S.D. ***P < 0.0001 using Student’s t test for results in comparison with RNMT plus GST. endo,
endogenous.
inhibition of RAM expression resulted in a reduction in cell
number, in this case to an average of 0.36-fold of the control
for three independent experiments. Expression of RAM–GFP
partially rescued cell proliferation, resulting in 0.71-fold cells
relative to control. Expression of GFP fusions of RAM 1–55, 56–
118, 1–90 and 91–118 did not rescue the growth defect of cells
depleted of endogenous RAM, with the average cell number not
significantly different to that of the GFP control. Therefore the
RAD (RAM 1–55), the NR domain (RAM 56–90) and the QYP
domain (RAM 91–118) are all critical for RAM function.
RAM 1–45 is necessary and sufficient to activate RNMT
In order to further probe the mechanisms by which RAM activates
RNMT, the domains of RAM which interact with RNMT were
mapped. The RNMT-interaction domain was previously mapped
c© The Authors Journal compilation c© 2014 Biochemical Society
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Figure 3 RAM stabilizes RNMT against proteosomal degradation
(A) HeLa cells were transfected with RAM or control (c) siRNA, and pcDNA4 RAM-GFP or RAM-GFP mutants. Western blots were performed to detect GFP, RAM, RNMT and β-tubulin. (B) HeLa cells
were transfected with pcDNA5 Fg-RAM and pcDNA5 HA-RNMT alone or in combination with the relevant vector controls. Two days following transfection, cells were incubated with 10 μM MG132,
20 μM clasto-lactacystin β-lactone (c-Lactacys) or vehicle control at 8 h before lysis. Western blots were performed to detect RAM, HA, RNMT and β-tubulin in cell extracts. Molecular masses are
indicated in kDa. endo, endogenous.
to the first 55 amino acids of RAM [12]. In order to determine
whether smaller fragments of RAM maintain significant interac-
tion with RNMT, a panel of RAM fragments was investigated
(Figure 1A). The direct interaction of RNMT and RAM was
investigated using recombinant proteins. GST–RAM and mutants
were incubated with RNMT and GST–RAM complexes were
purified on glutathione–agarose. RNMT co-purifying with GST–
RAM and mutants was detected by Coommassie Blue-stained
SDS/PAGE and Western blotting (Figure 2A). RNMT was found
to bind to GST–RAM, but not GST alone. RNMT also bound to
GST–RAM 1–55 and 1–45 equivalently to GST–RAM WT (wild-
type), and with lower affinity to GST–RAM 1–35 and 20–45. An
interaction between recombinant RNMT and GST–RAM 1–21 or
56–118 was not detected.
The RNMT–RAM interaction was analysed in mammalian
cells with similar results. HA–RNMT, GFP–RAM and RAM
mutants were expressed in HeLa cells and their interaction
was detected by immunoprecipitations performed with anti-
GFP and anti-HA antibodies (Figure 2B). In anti-GFP antibody
immunoprecipitations, RAM–GFP, but not GFP alone, was
observed to interact with HA–RNMT, visualized by Western
blotting to detect RNMT and the HA tag (Figure 2B,
lanes 2 and 3). In anti-HA immunoprecipitations, HA–
RNMT was observed to interact with RAM–GFP, but not
GFP alone, visualized by Western blotting to detect RAM
and the GFP tag. Anti-HA antibodies did not interact with
RAM–GFP when expressed in the absence of HA–RNMT
(Supplementary Figure S1 at http://www.biochemj.org/bj/457/
bj4570473add.htm). In the anti-GFP immunoprecipitates, an
interaction was observed between RAM–GFP 1–55, 1–45,
1–35, 20–45 and HA–RNMT. Conversely, in the anti-HA
immunoprecipitates, an interaction was observed between HA–
RNMT and the RAM–GFP mutants 1–55, 1–45, 1–35 and 20–45
(Figure 2B, lanes 4–9).
Previously, we demonstrated that the first 55 amino acids of
RAM are sufficient to activate RNMT in vitro [12]. Since we
observed that smaller fragments of this region could interact with
RNMT (Figures 2A and 2B), we investigated whether these same
RAM fragments are sufficient to activate RNMT. Recombinant
GST–RAM was incubated with RNMT and an in vitro cap
methyltransferase assay was performed. Briefly, RNMT and RAM
were incubated with the methyl donor, S-adenosylmethionine,
and a guanosine-capped transcript, G(5′)ppp(5′)X. Following the
reaction, the proportion of G(5′)ppp(5′)X N-7 methylated on
the guanosine was quantified (Figure 2C). As observed previously,
RAM WT and RAM 1–55 stimulated cap methyltransferase
activity more than 5-fold compared with GST control. RAM 1–45
also stimulated RNMT activity equivalently to the WT protein,
whereas the smaller RAM fragments, 1–21, 1–35, 20–45 and
56–118, had no effect on RNMT activity. Thus, although the
fragments 1–35 and 20–45 can interact with RNMT, they are not
sufficient to even partially activate the enzyme.
RNMT is stabilized by fragments of RAD
A key function of RAM is to stabilize RNMT protein [12]. The
domains of RAM required to stabilize RNMT were investigated
using the RAM mutant panel. In Figure 3(A), pcDNA5 RAM-GFP
and mutants were transfected into mammalian cells. Endogenous
RAM expression was reduced by transfection of RAM siRNA,
resulting in reduced RNMT expression (Figure 3A, lanes 1 and 2),
and co-transfection of RAM–GFP WT rescued RNMT expression
(Figure 3A, lane 3). Endogenous RNMT expression was also
rescued by expression of RAM–GFP 1–55, 1–45, 1–35 and 20–45.
This confirms that all RAM fragments that interact with RNMT,
including RAM 1–35 and 20–45, can rescue RNMT expression.
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Figure 4 RAM nuclear localization is dependent on the C-terminus
(A) HeLa cells were transfected with pcDNA5 Fg-RAM WT, truncation mutants or vector control. Immunoprecipitations (IP) were performed on normalized cell extracts using anti-Fg antibody–agarose
conjugates. Western blots were performed to detect Fg-tagged proteins, RNMT and β-tubulin in immunoprecipitates and extracts. Molecular masses are indicated in kDa. (B) HeLa cells were
transfected with control or RAM siRNA and with pcDNA5 Fg-RAM WT, truncation mutants or vector control. IF analysis was used to detect RAM localization and DAPI staining was used to detect
nuclei. The overlay of RAM IF, DAPI staining and bright field is also presented.
We investigated whether RAM stabilizes RNMT against
proteasome-mediated degradation (Figure 3B). HeLa cells were
transiently transfected with pcDNA5 Fg-RAM and pcDNA5
HA-RNMT, individually or in combination. As had been
seen previously, transfection of either construct alone resulted
in relatively low RAM and RNMT expression (Figure 3B,
lanes 2 and 3), whereas co-transfection of both constructs
resulted in significantly elevated expression of RAM and RNMT
(Figure 3B, lane 4). Incubation of cells with the proteasome
inhibitors MG132 or clasto-lactacystin β-lactone for 8 h prior
c© The Authors Journal compilation c© 2014 Biochemical Society
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Figure 5 RAM nuclear localization is dependent on the C-terminus
(A) HeLa cells were transfected with pcDNA5 RAM-GFP, RAM-GFP mutants or GFP. Fluorescence microscopy was used to detect GFP localization in HeLa cells and DAPI staining was used to detect
nuclei. An overlay of GFP fluorescence, DAPI staining and bright field is presented. (B) The ratio of nuclear to cytoplasmic GFP fluorescence was quantified. The average for 12 images is presented
and error bars indicate +− S.D. ***P < 0.0001 using Student’s t test for average ratio in comparison with GFP control.
to lysis increased RNMT and RAM expression when cDNAs
were transfected individually to levels approaching those found
in the RNMT–RAM co-transfection (Figure 3B, lanes 6 and 7).
However, when RNMT and RAM were co-expressed, proteasome
inhibitors had negligible effect on their expression (Figure 3B,
lane 8). These data are consistent with the RNMT–RAM complex
protecting both proteins from proteasome-mediated degradation.
RAM QYP domain contains a nuclear localization motif
RAM is a protein which functions in the nucleus to activate
and stabilize RNMT. RNMT has three classical lysine/arginine
NLSs (nuclear localization signals), and mutation of all three
simultaneously results in mislocalization of RNMT and loss of
cell viability [13]. RNMT can be imported independently of
RAM, since a mutant of RNMT, which does not bind RAM,
is recruited to the nucleus [8]. Conversely, the mechanism by
which RAM enters the nucleus is not known, including whether
it requires RNMT.
To investigate the RAM domains governing nuclear entry,
HeLa cells were simultaneously transfected with RAM siRNA
to suppress expression of the endogenous protein and with
pcDNA5-based constructs to express Fg-RAM WT and mutants
(Figures 1A and 4A). The Fg-RAM cDNAs used throughout
the present study have silent mutations which renders them
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resistant to RAM siRNA. IF performed using polyclonal anti-
RAM antibodies was used to detect RAM (Figure 4B). Anti-
RAM antibodies were used rather than anti-Fg antibodies, since
we have not found the latter to be effective at detecting Fg–RAM
by IF (T. Gonapoulos-Pournatzis and V.H. Cowling, unpublished
work). The anti-RAM antibodies were raised against the WT
protein and recognize epitopes throughout RAM (Figure 2) [12].
In control transfections, endogenous RAM was detected as a
nuclear protein by co-localization with the DNA stain DAPI.
Transfection of RAM siRNA inhibited the detection of RAM,
confirming the specificity of the anti-RAM antibodies. Fg–RAM
WT was detected predominantly in the nucleus, whereas Fg–
RAM 1–55 and 1–90 were distributed throughout the nucleus
and cytoplasm, suggesting that amino acids 91–118 are required
for nuclear entry. However, Fg–RAM 1–55 and Fg–RAM 1–
90 are poorly expressed, and Fg–RAM 56–118 and 91–118
were undetectable by Western blot or IF (Figure 4A and results
not shown). Furthermore, some of these truncation mutants
may be small enough to enter the nucleus by passive diffusion
and therefore may not provide useful information about the
localization of the WT protein. Owing to the limitations of Fg–
RAM mutant expression, the subcellular localization of RAM–
GFP WT and mutants was also investigated (Figure 5A). The
RAM–GFP mutants used, 1–55, 56–118, 1–90 and 91–118, were
all detectable by IF (Figure 5A) and Western blotting performed
on cell extracts (Figure 1B). GFP expressed alone was distributed
throughout the nucleus and cytoplasm, whereas RAM–GFP was
predominantly nuclear (Figure 5A). Similar to Fg–RAM, RAM–
GFP 1–55 exhibited a localization defect and was distributed
throughout the nucleus and cytoplasm, whereas RAM–GFP 56–
118 and 91–118 were predominantly nuclear. Since RAM 56–118
and 91–118 do not bind to RNMT (Figure 2), RAM does not
require RNMT for nuclear entry. To quantify these observations,
the nuclear to cytoplasmic ratio was determined for RAM–GFP
and mutants using confocal microscopy (Figure 5B). RAM–GFP
WT, 56–118 and 91–118 had a significantly increased nuclear to
cytoplasmic ratio when compared with GFP alone. Conversely,
RAM–GFP 1–55 and 1–90 exhibited a nuclear to cytoplasmic
ratio equivalent to GFP alone and therefore a putative NLS maps
to RAM 91–118.
RAM PY motifs are required for nuclear entry
RAM does not contain a classical lysine/arginine-based NLS,
but the QYP domain (91–118) does contain two putative PY-
NLSs surrounding P98Y (PY1) and P114Y (PY2; Figure 1) [14,15].
PY-NLSs mediate nuclear localization via binding to the nuclear
transport protein Kapβ2 [16]. Three mutants were created to study
the role of the putative RAM PY-NLSs. PY1AA has P98A/Y99A
mutations, PY2AA has P114A/Y115A mutations and PY1/2AA
has a combination of these mutations. RAM–GFP and PY mutants
were expressed in HeLa cells resulting in equivalent expression
(Figure 6B). The subcellular localization of these mutants was
investigated using confocal microscopy (Figure 6A). RAM–GFP
PY1/2AA was mislocalized to the cytoplasm and its average
nuclear to cytoplasmic ratio was not significantly different from
the GFP control (Figure 6C). In this experimental scenario the
most influential NLS is PY1, since the PY1AA mutation had a
significant effect on the RAM–GFP nuclear to cytoplasmic ratio,
whereas the PY2AA mutation did not. However, since mutating
both PY motifs simultaneously had the greatest effect on the
nuclear to cytoplasmic ratio, both motifs appear to contribute to
localization.
Since the PY mutants are defective for nuclear entry, their
ability to support cell proliferation was investigated (Figure 6D).
HeLa cells were depleted for endogenous RAM using RAM-
directed siRNA and transfected with pcDNA5 RAM-GFP, PY
mutants or GFP alone. After 3 days cells were counted and
expressed as values relative to cells transfected with the control
siRNA/pcDNA5 GFP (Figure 6D). Inhibition of RAM expression
resulted in a reduction in cell number, to an average of 0.34-fold
compared with the control for three independent experiments.
Expression of RAM–GFP partially rescued cell proliferation
resulting in 0.66-fold cells relative to control. Cells expressing
RAM–GFP PY1AA, PY2AA and PY1/2AA did not proliferate at
a significantly different rate to the GFP control.
Kapβ2 mediates RAM nuclear entry
Since the PY-NLSs are required for nuclear entry of RAM, the
functional relationship between RAM and the nuclear transport
protein Kapβ2, which binds to PY-NLSs, was investigated
[15,16]. To investigate whether RAM and Kapβ2 interact
directly, recombinant GST–RAM and GST were incubated with
recombinant Kapβ2. GST–RAM and GST were purified by
glutathione–agarose and Kapβ2 was only detected in a complex
with GST–RAM (Figure 7A). The Kapβ2–RAM interaction was
also observed in mammalian cells (Figure 7B). Myc–Kapβ2 and
GFP–RAM were expressed in HeLa cells. Immunoprecipitation
of Myc–Kapβ2 from cell extracts using anti-Myc tag (9E10)
antibodies resulted in co-immunoprecipitation of GFP–RAM, but
not GFP alone. The interaction of Kapβ2 with RAM was inhibited
by the PY1AA or PY1/2AA mutations and reduced by the PY2AA
mutation (Figure 7C). This is consistent with the PY1AA mutation
exhibiting a greater defect in nuclear localization compared with
the PY2AA mutation (Figure 6C). If the Kapβ2–RAM interaction
is mediating nuclear entry, then inhibiting Kapβ2 expression
should reduce RAM nuclear localization. Kapβ2 expression was
inhibited with two independent siRNAs and a reduction in Kapβ2
transcript and protein was observed (Figures 7D and 7E). A
reduction in Kapβ2 expression did not alter RAM expression
(Figures 7D and 7E), but did result in RAM mislocalization to
the cytoplasm (Figure 7F), indicating that Kapβ2 is rate-limiting
for nuclear entry of RAM. A desirable experiment at this stage
would be to reverse the observations made with Kapβ2 siRNAs
using co-transfection of siRNA-resistant Kapβ2 cDNA. However,
we were unable to overexpress Kapβ2, even using inducible
constructs (results not shown). As independent evidence that
Kapβ2 mediates nuclear entry of RAM, cells were transfected
with a plasmid encoding Myc-tagged M9M, a chimaeric PY-
NLS peptide which adheres to Kapβ2 effectively blocking cargo
binding [17]. M9M was detected by IF performed with 9E10
antibodies, which recognize the Myc epitope. The presence of
M9M inhibited nuclear import of RAM consistent with Kapβ2
mediating nuclear import of RAM (Figure 7G).
RNMT localization was not detectably influenced by interfer-
ence with RAM or Kapβ2 function. Expression of RAM trunca-
tion mutants (Supplementary Figure S2A at http://www.biochemj.
org/bj/457/bj4570473add.htm), inhibition of Kapβ2 expression
(Supplementary Figure S2B) or inhibition of Kapβ2 activity
(Supplementary Figure S2C) did not alter RNMT nuclear
localization. Thus RAM and RNMT are imported into the nucleus
using independent mechanisms (Figure 8). Once nuclear, RAM
stabilizes and activates RNMT.
DISCUSSION
Formation of the 7-methylguanosine cap structure on RNA pol
II transcripts mediates key events throughout its lifetime and is
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Figure 6 RAM nuclear localization is dependent on the PY domains
(A) HeLa cells were transfected with pcDNA5 RAM-GFP, RAM-GFP PY/AA mutants or GFP control. Fluorescence microscopy was used to detect GFP localization and DAPI staining was used to detect
nuclei. An overlay of GFP fluorescence, DAPI staining and bright field is presented. (B) Western blots were performed to detect GFP, RNMT, Kapβ2 and β-tubulin in cell extracts. Molecular masses
are indicated in kDa. (C) The ratio of nuclear to cytoplasmic GFP fluorescence was quantified. The average of 12 images is presented and error bars indicate +− S.D. ***P < 0.0001 and *P < 0.01
using Student’s t test for average ratio in comparison with the GFP control. (D) HeLa cells were co-transfected with RAM or control siRNA, and pcDNA5 RAM-GFP, RAM-GFP PY/AA mutants or GFP.
At 3 days after transfection cells were counted and the number expressed as relative to control/pcDNA5 GFP transfection. The histogram depicts the average for three independent experiments and
the error bars indicate +− S.D. **P < 0.001 using Student’s t test relative to GFP control.
critical for gene expression [1]. The enzymes which catalyse its
addition, RNGTT and RNMT–RAM, are rate-limiting for gene
expression and cell proliferation, and their nuclear localization
is required for cell viability [10,12,13]. We previously described
three domains of the RNMT activating mini-protein: RAM, an
N-terminal RAD; a central RNA-binding domain (NR domain);
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Figure 7 Kapβ2 mediates RAM import
(A) Recombinant GST–RAM or GST was incubated with recombinant Kapβ2. GST–RAM and Kapβ2 complexes were purified on glutathione–Sepharose, resolved by SDS/PAGE and visualized by
Western blotting. Molecular masses are indicated in kDa. (B) HeLa cells were transfected with pcDNA5 Myc-Kapβ2 or vector control and pcDNA5 RAM-GFP or GFP. Immunoprecipitations (IP) were
performed on cell extracts using anti-Myc antibodies. Western blots were performed to detect Myc–Kapβ2, RAM and β-tubulin in inputs and immunoprecipitates. (C) HeLa cells were transfected with
pcDNA5 Myc-Kapβ2 or vector control (c) and pcDNA5 RAM-GFP, RAM-GFP PY/AA mutants or GFP. Immunoprecipitations were performed on cell extracts using anti-Myc antibodies. Western blots
were performed to detect Myc–Kapβ2, RAM and β-tubulin in inputs and immunoprecipitates. (D) HeLa cells were transfected with two independent Kapβ2 siRNAs or control siRNA. After 2 days
RNA was extracted and real-time PCR performed to detect expression of Kapβ2, RNMT and RAM. The average result for three independent experiments is presented and the error bars indicate +− S.D.
(E) Western blots were performed to detect Kapβ2, RNMT, RAM and β-tubulin in cell extracts. (F) IF was used to detect RAM localization and DAPI staining was used to detect nuclei. The overlay
of RAM IF, DAPI staining and bright field is also presented. si, siRNA. (G) HeLa cells were transfected with pcDNA3.1 Myc-M9M or vector control. IF was used to detect RAM and Myc-M9M. DAPI
staining was used to detect nuclei. The overlay of RAM or RNMT, DAPI staining and bright field is presented.
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Figure 8 Summary of RAM functional domains
Depictions of the functionality of the RAM mutants used in the present study and previously [12].
and a C-terminal uncharacterized domain which we called the
QYP domain on the basis of the enrichment of glutamine,
tyrosine and proline residues. In the present study we observe
that all three domains of RAM are required to support cell
proliferation (Figure 1).
RAM nuclear localization is mediated by Kapβ2
Cap methylation is a process which occurs predominantly during
the early stages of transcription, and therefore nuclear entry of
RAM is critical for its function of activating and stabilizing
RNMT. A major finding of the present study is the identification
of the mechanism by which RAM is imported into the nucleus.
We demonstrate that RAM has two PY-NLSs based around P98Y
(PY1) and P114Y (PY2), which co-operate to promote nuclear
import of RAM. The PY-NLS motif has a loose consensus
sequence described as consisting of N-terminal hydrophobic
or basic motifs and a C-terminal RX2–5PY motif [14]. Since
the consensus sequence (and structure) is loose, PY motifs
can only be confirmed by experimentation. Mutation analysis
demonstrated that simultaneous mutation of both RAM PY-
NLSs causes a localization defect indistinguishable from the
GFP control (Figure 6). PY1 has a more significant role in
nuclear import than PY2, since mutation of PY1 results in a more
significant defect than mutation of PY2. PY motifs are recognized
by Kapβ2 (importin β), which binds to cargos and nucleoporins,
thus targeting cargos to the nuclear pore complex [15]. We
established that Kapβ2 binds to RAM directly via an interaction
with the PY motifs (Figure 7). Inhibiting Kapβ2 expression with
siRNA or inhibiting Kapβ2 function with the M9M inhibitor
inhibited RAM import, confirming the functional interaction of
Kapβ2 and RAM. Therefore RAM, in common with many other
RNA-binding proteins, utilizes Kapβ2-dependent nuclear entry
[18–22].
RNMT is imported into the nucleus by an alternative
mechanism to RAM. RNMT contains three functional classical
nuclear localization signals and binds to the importin-α–importin-
β heterodimer [13]. Previously, we demonstrated that RNMT
import does not require RAM. RNMT mutants which do not bind
to RAM do not exhibit a localization defect [8]. In agreement
with this finding, in the present study we confirm that import of
endogenous RNMT is not significantly affected when the RAM–
Kapβ2 import mechanism is inhibited (Supplementary Figure
S2). However, we note that, although we cannot detect a defect
in RNMT nuclear localization when we interfere with the RAM–
Kapβ2 interaction or function, we cannot discount that a fraction
of RNMT is imported in a complex with RAM (and vice versa).
RNMT activation requires the entire interaction domain
Previously we had established that the first 55 amino acids of
RAM are sufficient to activate RNMT. In the present study
we determine that, although smaller fractions of this region
are sufficient to interact with RNMT and stabilize the protein
(Figures 2 and 3), the first 45 amino acids of RAM are necessary
and sufficient to activate RNMT (Figure 2C). Currently the effect
of RAM 1–45 on RNMT structure is unknown and further studies
will be required to determine whether RAM alters the RNMT
active site conformation and/or substrate and product affinities.
In summary, we have identified RAM as having three domains;
an N-terminal activation domain (RAD), a central RNA-binding
domain (NR domain) and a C-terminal nuclear localization
domain (QYP), which contains two PY-NLSs (Figure 8). The
QYP domain is critical for RAM to enter the nucleus, where it
activates RNMT resulting in mRNA cap methylation.
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RAM function is dependent on Kapβ2-mediated nuclear entry
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Figure S1 RAM and RNMT interact
HeLa cells were transfected with pcDNA5 HA-RNMT or vector (Vec) control and pcDNA4
RAM-GFP or GFP vector control. Immunoprecipitations (IP) were performed with anti-HA or
anti-GFP antibodies. Western blots were performed to detect GFP, RAM, HA and RNMT in the
inputs and immunoprecipitates. * indicates cross-reacting antibody heavy or light chain.
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Figure S2 RNMT nuclear localization is independent of RAM
(A) HeLa cells were transfected with RAM–GFP WT, truncation mutants (RAM 1–55, RAM 56–118 and RAM 91–118) or GFP vector control. IF microscopy was used to detect RNMT and DAPI
staining was used to detect nuclei. (B) HeLa cells were transfected with control or two independent Kapβ2 siRNAs (si). IF microscopy was used to detect RNMT localization and DAPI staining was
used to detect nuclei. (C) HeLa cells were transfected with pcDNA3.1 Myc-M9M or vector control. IF was used to detect RNMT and Myc–M9M. DAPI staining was used to detect nuclei. The overlay
of RNMT, DAPI staining and bright field is presented.
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